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Abstract
Background: It is unknown whether interventions known to improve the healthcare response to domestic violence
and abuse (DVA)—a global health concern—are effective outside of a trial.
Methods: An observational interrupted time series study in general practice. All registered women aged 16 and
above were eligible for inclusion. In four implementation boroughs’ general practices, there was face-to-face,
practice-based, clinically relevant DVA training, a prompt in the electronic medical record, reminding clinicians to
consider DVA, a simple referral pathway to a named advocate, ensuring direct access for women to specialist
services, overseen by a national, health-focused DVA organisation, fostering best practice. The fifth comparator
borough had only a session delivered by a local DVA specialist agency at community venues conveying
information to clinicians. The primary outcome was the daily number of referrals received by DVA workers per 1000
women registered in a general practice, from 205 general practices, in all five northeast London boroughs. The
secondary outcome was recorded new DVA cases in the electronic medical record in two boroughs. Data was
analysed using an interrupted time series with a mixed effects Poisson regression model.
Results: In the 144 general practices in the four implementation boroughs, there was a significant increase in
referrals received by DVA workers—global incidence rate ratio of 30.24 (95% CI 20.55 to 44.77, p < 0.001). There was
no increase in the 61 general practices in the other comparator borough (incidence rate ratio of 0.95, 95% CI 0.13
to 6.84, p = 0.959). New DVA cases recorded significantly increased with an incident rate ratio of 1.27 (95% CI 1.09
to 1.48, p < 0.002) in the implementation borough but not in the comparator borough (incidence rate ratio of 1.05,
95% CI 0.82 to 1.34, p = 0.699).
Conclusions: Implementing integrated referral routes, training and system-level support, guided by a national health-
focused DVA organisation, outside of a trial setting, was effective and sustainable at scale, over four years (2012 to
2017) increasing referrals to DVA workers and new DVA cases recorded in electronic medical records.
Keywords: Domestic violence abuse, Complex, Evaluation, Improvement, Implementation, Interrupted time-series,
Observational
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Background
Domestic violence and abuse (DVA) is a global health and
societal concern [1]. It is a violation of human rights which
damages health, posing a challenge to public health and clin-
ical practice [2, 3]. World Health Organization [4], National
Institute for Health and Care Excellence guidelines [5] and
the most recent UK Government Department of Health &
Social Care guidance [6] all support greater health sector in-
volvement, to improve the healthcare of those affected by
DVA. Most recently, the Guttmacher-Lancet Commission
placed detection and management of gender-based violence,
central to delivering sexual and reproductive health for all
[7]. In most settings, including high-income countries,
healthcare is still not responding adequately to violence
against women, which will most commonly be DVA [8].
This response’s contribution to delivering better healthcare
for all has not been realised [9]. Ten years following the com-
pletion of our cluster randomised controlled trial demon-
strating the effectiveness of IRIS—Identification and Referral
to Improve Safety of women affected by DVA—a complex,
system-level, training, support and referral programme, de-
signed to improve the primary healthcare response to DVA
[10], we now report an analysis of a population-wide imple-
mentation evaluation of IRIS, over four years (2012 to 2017).
A previous systematic review of interventions to im-
prove clinicians’ response to DVA [11], updated and de-
veloped to focus only on high-quality, low risk of bias
trials, measuring outcomes changing either clinicians’
behaviour (identifying and referring cases) or patient
outcomes, found three studies [ 10, 12, 13], two of which
[10, 12] were identified in the original systematic review
[11]. These higher-quality studies supported the review’s
overall conclusion that the best strategy to improve cli-
nicians’ responses to DVA is training clinicians, face-to-
face (as opposed to online interventions that have not
been evaluated for actual behaviour change)—with
optimum duration and precise elements of training un-
defined—whilst increasing all staff’s understanding of
DVA (not just awareness). Two of these studies sup-
ported a clinical case-finding approach [10, 12], with one
intervention including system-supportive interventions–
incorporating clinical reminders on identifying DVA
within consultations and direct access for women to
DVA services within the safe space of healthcare settings
[10]. The most recent third study did not support a sys-
tem of care for postal screening, followed by general
practice invites to women affected by DVA [13]. Out of
the three trials, the IRIS trial intervention was unique as
it nurtured and established greater health services’ par-
ticipation by linking NHS statutory primary care to the
multi-sectoral response to violence against women, via
the DVA agency-employed advocate educator [10]. The
IRIS trial, based on 24 intervention general practices
with controls, in two English cities (London and Bristol),
over one year, reported an increase in recorded DVA
identification (three-fold), referrals made for advocacy
(seven-fold) and referrals’ discussion (22-fold). The
intervention consisted of training sessions for the whole
practice team, a focus on clinically relevant DVA case
finding, using the accurate Humiliation, Afraid, Rape,
Kick (HARK) tool [14, 15], embedded in the electronic
medical record (EMR), reminding clinicians to listen for
and consider DVA. Qualitative analysis nested within the
original IRIS trial showed that women had positive experi-
ences about being asked about abuse, when clinically indi-
cated by health professionals and contact with DVA
advocates [16]. Health professionals viewed IRIS as an ac-
ceptable intervention but were concerned that their four
hours of training was lengthy [17]. Modelling with trial data
showed that the IRIS intervention was cost-effective [18].
Following the trial, the IRIS intervention has been
funded in 41 English and Welsh, urban and rural sites.
In one quarter of sites, funding has stopped. Secure
longer-term funding allowing more stable healthcare ser-
vices’ involvement, at a much larger scale than at
present, requires more evidence that the intervention is
effective outside the trial context. We hypothesised that
this system-level programme would be effective and
sustained outside of a trial.
Methods
The aim of this study was to determine whether IRIS is
effective when implemented in primary care outside a
trial setting, in multiple sites, over four years. For full de-
tails of study design, participants, procedures, interven-
tions, and data sources, see our protocol paper [19]. We
have used the revised Standards for QUality Improve-
ment Reporting Excellence (SQUIRE 2.0) [20] for report-
ing this evaluation (see Additional file 1).
Study design and participants
Observational implementation study [21] conducted a
segmented regression interrupted time series (ITS) ana-
lysis [22] of routinely collected longitudinal data, includ-
ing over a baseline year prior to implementation, from
general practices that implemented the IRIS programme
in four boroughs and general practices invited to attend
a DVA education session, more akin to usual care in a
neighbouring borough.
All northeast London boroughs that funded IRIS were
included in this study (A, B, C and D). The one neigh-
bouring northeast London borough (E) that declined to
fund IRIS instead organised lower cost DVA education
sessions. Hence, E served as a contemporaneous non-
random comparator borough. Randomisation was not
possible. All data from the implementation boroughs
and the comparator borough were collected within the
same 53-month study period (from November 2012 to
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the end of March 2017). All general practice-registered
women aged 16 and above were eligible for inclusion in
this study.
This study used only anonymised observational data,
obtained assessing routine clinical care so individual
consent of women was not required. Prior to the start of
this study, advice was sought from the research ethics
committee chair with written approval given for this
work as an evaluation of routine care.
Processes
Our case definition of DVA against women was physical,
sexual, psychological or emotional abuse, including
threatening behaviour, either from a partner, ex-partner
or an adult family member, currently or historically. In
all areas, women affected by DVA could be identified by
a clinician and offered a referral to a DVA worker.
Women could also self-refer if they saw publicity mater-
ial displayed within a practice.
The IRIS model has five core components: 1. practice-
based training—two two-h clinical sessions, one h for ad-
ministration staff and two-h refresher training, offered
two years later; 2. a local GP appointed as an IRIS clinical
lead delivers DVA training relevant to providing clinical
care; 3. a prompt to consider DVA, with HARK, in the
EMR triggered by codes for health conditions or symp-
toms associated with DVA; 4. a named DVA specialist, the
IRIS advocate educator, employed by and based at a local
DVA service jointly delivers training (as above) with the
clinical lead; and 5. this IRIS advocate educator receives
referrals directly from trained clinicians and sees patients
affected by DVA, usually within the practice, unlike usual
primary care settings, dispensing expert advocacy and en-
suring direct access for women to specialist abuse services.
We have described the IRIS model using the TIDieR
checklist [23] (see Additional file 2). IRISi (IRIS interven-
tions), a national, health-focused DVA organisation, brings
experience and knowledge of starting up 37 other local
IRIS services, facilitating negotiations and strengthening
the National Health Services’ (NHS) relationship with
DVA agencies. IRISi using data (nationally collected, ana-
lysed and monitored) steers implementation, on-going
support, staff recruitment and training, for each local IRIS
service. Staff mix is crucial as reported in the implementa-
tion process evaluation [24].
The other DVA education model delivered in the
comparator borough comprised a session, conveying in-
formation about DVA, located in community venues
(not in general practices), led by a local DVA service
provider (not delivered by clinicians), no prompt to
consider DVA within the EMR and no named advocates
receiving referrals. This is the most usual type of DVA
education for healthcare providers in England and Wales
and represents usual care. Globally, support to provide a
proficient healthcare response to DVA is even more ru-
dimentary or absent.
Outcomes
Our primary outcome was the daily number of referrals
received by DVA workers per 1000 women registered in
a general practice. This is an intermediate outcome
measure, on a causal pathway towards decreased inci-
dence of DVA, possibly better mental health and im-
proved quality of life [25]. In boroughs A and D, there
was one sole DVA service provider, receiving all refer-
rals, from which data were collected. In boroughs B and
C, there were several DVA service providers; in these,
we collected referral data from the major DVA agency,
receiving more than 80% of referrals in that area. Smaller
DVA service providers, receiving less than 20% referrals,
in these two areas only, did not routinely record their
client’s registered general practice. In the comparator
borough (E), there was a ‘One-Stop Shop’ through which
all referrals to multiple DVA service providers were re-
ceived, and from which we collected referral data.
Our secondary outcome measure was the number of
women in whose EMR first usage of a DVA identifica-
tion code occurred, per 1000 women registered in a gen-
eral practice, corresponding to the incidence of DVA
cases identified and recorded by general practices. These
data were only available in boroughs C and E, as they
had data sharing agreements. The type of contact that
referred women had with IRIS advocate educators was
also collected.
Statistical analysis
Power calculation
Following the introduction of IRIS, we wanted to be able
to detect a doubling of the referral rate, thus an incident
rate ratio (IRR) of at least two, with 90% power, at the
5% significance level. IRRs compare the periods before
and after the first DVA session delivery. They are based
on regression coefficients. The regression coefficient is
the constant that represents the rate of change of refer-
rals received by DVA workers from clinicians, as a func-
tion of change over time in days, before and after
implementation of the DVA package. For the power cal-
culation, we assumed that the implementation of IRIS by
each general practice occurred at different times uni-
formly over the time period. We anticipated that there
would be approximately 180 general practices in the ITS
evaluation. Based on the data from the original IRIS trial
[10], we estimated that with an average of 3000 eligible
women per practice, a typical practice average referral
rate at baseline of 4.5 referrals made and received by the
DVA agency per 100,000 registered women aged 16
years and above, per month, with this rate varying be-
tween practices with a 95% normal range of 1.7 to 12.2
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per 100,000 per month. Simulations of monthly counts
with a Poisson distribution showed that 17 months of
data were required to detect a doubling of the referral
rate. We collected data over at least 24 months, in order
to ensure that any seasonality in referral rates did not
impact on our results. Simulation using the SimSam
package in Stata was used to calculate the sample size
[26]. For this sample size calculation and the code that
enables it to be reproduced, see Additional file 3.
For the analysis, the effect of both DVA programmes
was defined by the delivery of the first training session
for IRIS and the information session for the other DVA
education model. Hence, our impact model assumed a
step change model, with these educational sessions if
effective thought to be key to a prompt outcome re-
sponse, with an immediate and on-going impact. This
was examined using practice-level daily data, before and
after the date of these sessions respectively, to detect
whether either DVA programme had an effect signifi-
cantly greater than the underlying secular trend. The
primary and secondary outcome measures were analysed
using an ITS segmented approach with a mixed effects
Poisson regression model. This ITS model included a
random effect of practice and fixed effects of education
(pre or post in any given day in any given practice), the
gradient of the underlying time trend, the change in gra-
dient following the teaching, site (borough), and month
and day of the week to allow for any seasonal effect of
time. In order to model over-dispersion of daily frequen-
cies, we included a random effect of day nested within
the random effect of practice in our Poisson regression
model. To control for the available population size at
any one time, we adjusted for the log-transformed num-
ber of women aged 16 years and above registered at a
practice for that quarter, as an offset variable in the ana-
lysis. The general practices that did not receive any DVA
session, had an unknown number of women registered,
had missing training dates or had closed were excluded
from the statistical analysis; as were the observations on
the day of DVA session delivery, as uncertain whether
these observations occurred before or after the educa-
tion sessions.
A global estimate of the IRR was calculated by fitting
an ITS regression to the combined data from all four
boroughs where IRIS was implemented. A z test was
used to test whether the coefficient from the ITS Pois-
son regression model was different from 0 (or whether
the ITS Poisson regression model’s exponentiated coeffi-
cient was different from one), generating a p value. ITS
regression models were also fitted separately for each of
the five boroughs. The presence of autocorrelation was
assessed through sensitivity analysis using clustered
standard errors in the ITS regression model. General
practices were defined as the cluster.
Sub-group analyses
To determine whether there was heterogeneity in the
treatment effect (i.e. impact of IRIS implementation)
across the different boroughs, the effect estimates were
graphically displayed in a forest plot, and Cochran’s test
of heterogeneity [27] was calculated. The same approach
was taken to explore whether the IRIS implementation
effect differed dependent upon a practice’s level of
deprivation, using the Index of Multiple Deprivation, for
which “0” denotes the least deprivation and “100” the
most deprivation [28]. For the purpose of this analysis,
deprivation score was grouped into three (scores 10 to
≤ 30, > 30 to < 30.65, > 30.65), with the category bound-
aries chosen to create an equal number of practices in
each group. The effect estimates were also graphically
displayed in a forest plot, and Cochran’s test of hetero-
geneity [27] was calculated. All sub-group analyses were
pre-specified and done in Stata V14 (StataCorp LP,
College Station, TX).
Results
Table 1 shows largely comparable characteristics, includ-
ing population size, of the participating five boroughs
(A, B, C, D and E). The general practices that were
included in the ITS analysis were consistently less de-
prived than all general practices in each of the five bor-
oughs. All the boroughs have diverse populations with
substantial proportions of non-white ethnicity, with the
highest proportion in the comparison borough.
Table 2 shows a summary of the data collected, with
absolute numbers of referrals received by DVA service
providers from general practices, new DVA cases identi-
fied and recorded by general practices and explanation
of missing data. In the boroughs where IRIS was imple-
mented (A, B, C and D), 144 general practices were
funded to receive IRIS training. Twenty-two general
practices did not receive it. Three practices had an un-
known number of women registered. Two practices had
missing training dates. One practice closed. Hence, 116
practices (81%) were included in the analysis. In borough
E, 27 general practices out of 61 sent no staff to their
DVA session, so 34 (56%) practices were included in the
analysis. The IRIS programme was implemented in north-
east London from November 2013. IRIS continued to be
funded in all four implementation boroughs (A, B, C and
D) at the end of the data collection on 31 March 2017. In
the comparator borough E, the DVA information sessions
were delivered from May 2014. The data collection period
included the year preceding the implementation, in all five
boroughs. This was a total of 53months, from November
2012 to the end of March 2017.
The global IRR for referrals received in the four boroughs
where IRIS was implemented was 30.24 (95% CI 20.55 to
44.77, p < 0.001). Table 3 shows the IRRs for referrals
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Table 1 Characteristics of five participating boroughs (A, B, C, D and E)
London
borough
Sub-
region
Population characteristics Recorded crime and incidents
Female,
thousands
Mean Index of Multiple
Deprivation of all general
practices
Mean Index of Multiple Deprivation
of only general practices included in
the analysis
Non-
white
ethnicity,
%
Domestic incidents
per 1000 female
population
Domestic
homicides
2009–2014, n
A North 129.8 48 30 39.0 53.5 6
B North 96.9 33 29 33.7 42.6 2
C East 105.2 36 31 54.8 75.7 10
D North 91.6 34 23 31.8 60.3 4
E East 116.8 48 27 71.0 71.1 11
All data relates to financial year 2013/2014 with data source Mayor of London Office for Policing and Crime—except Index of Multiple Deprivation (IMD) is the
2015 score [28]
Table 2 Data summary—referrals received by DVA service providers from general practices and new DVA cases’ recorded
identification by general practices
Boroughs A B C D E
Number of practices
for which DVA
service funded
33 (50%) 39 (100%) 37 (100%) 35 (100%) 61 (100%)
Number of practices
excluded (reasons)
2 (6%) (both trained—1
closed, 1 missing list size
data)
9 (23%) (6 untrained; 3
trained—2 missing training
dates, 1 very irregular list
size data)
5 (13%) (5 untrained) 12 (34%) (11
untrained; 1
trained—very
irregular list size
data)
27 (44%) (27
untrained)
Number of practices
included
31 (94%) 30 (77%) 32 (87%) 23 (66%) 34 (56%)
Observation period
(number of days)
15 November 2012 to 31
March 2017 (1598)
14 March 2013 to 31
March 2017 (1479)
02 October 2013 to 31
March 2017 (1277)
29 January 2014
to 31 March
2017 (1158)
01 January 2014 to
31 December
2015 (730*)
First session delivery
date
15 November 2013 14 March 2014 02 October 2014 29 January 2015 15 May 2014
Number of referrals
received by DVA
service providers
from general
practices
278 270 394 123 41
Number of referrals
excluded (reason)
13 (5%) (1 on same day as
training; 12 from untrained
practices or from two
excluded practices—as
above)
7 (3%) (3 on same day as
training; 1 from an
excluded practice; 3 from
practices outside of
Camden)
0 (0%) 3 (2%) (2 from
untrained
practices; 1 from
an unknown
practice)
22 (54%) (20 from
untrained practice;
2 from unknown
practices)
Mean no. of referrals
per day (variance)
0.005 (0.006) 0.006 (0.006) 0.01 (0.01) 0.005 (0.005) 0.0008 (0.0008)
Number of new DVA
cases recorded
identification by
general practices
– – 2808 – 2260
Number of DVA
identification codes
excluded (reason)
– 265 (2 on same day as
training; 19 no
accompanying date
provided; 244 from
excluded practices)
– 913 (4 no
accompanying
date provided; 909
from excluded
practices)
Mean no. of new
DVA cases identified
per day (variance)
– – 0.064 (0.071) – 0.03 (0.03)
*The observation period in borough E for referrals received is smaller than that for DVA codes (for which it was 1417 days, from 15 May 2013 to 31 March 2017)
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received in all five boroughs with the delivery of their separ-
ate DVA sessions. The IRRs for the individual boroughs (A,
B, C and D) are consistent with the global IRR, representing
a large increase in the number of referrals received with the
first training session delivery, in contrast to borough E that
has no improvement in referrals received with its session
delivery (IRR 0.95, 95% CI 0.13 to 6.84, p = 0.959). Figure 1
shows the average daily referral rate per 1000 women regis-
tered in the IRIS boroughs’ general practices (A, B, C and
D), plotted against time centred around the day of delivery
of their first IRIS training session, illustrating the large ef-
fect of IRIS implementation on referrals, and post-
implementation shows that IRIS has a sustained effect on
the increased numbers of referrals received. This scatter
diagram is consistent with our chosen step change impact
model, supporting that this model fitted the data well
across all four boroughs. Figure 2 shows that the average
daily referral rate per 1000 women registered in borough E,
before and after the day of delivery of their DVA session,
did not significantly differ. The result from the sensitivity
analysis with clustered standard errors was IRR 28.78 (95%
CI 16.38 to 50.56, p < 0.001). These results allow for poten-
tial autocorrelation and are consistent with our main find-
ings. The estimated effect of IRIS’ first training session
delivery on referrals received is not significantly different in
the four implementation boroughs (see Fig. 3), nor affected
by socioeconomic status, as reflected by the deprivation
level of each practice (see Fig. 4): low deprivation
(score 10 to ≤ 30, medium (score > 30 to < 30.65) and
high (score > 30.65). Cochran’s heterogeneity test
shows there is no significant heterogeneity between
boroughs or deprivation score level, producing p
values of 0.460 and 0.850 respectively. IRISi reports
that nationally, IRIS advocate educators have contact
with and support 85% of the patients that are referred
to them from general practice (IRIS National Report
2018).
Table 4 shows IRRs for new DVA cases identified and
recorded by general practices in boroughs C and E with
the delivery of DVA sessions. The IRR in borough C was
1.27 (95% CI 1.09 to 1.48, p < 0.002), demonstrating that
there is a significant increase in the number of new
DVA cases identified and recorded by general practices,
on average with the first IRIS training session delivery.
This increase is not seen with the other DVA model’s in-
formation session delivery in borough E (IRR = 1.05, 95%
CI 0.82 to 1.34, p = 0.699).
Discussion
Our interrupted time series analysis of data from five
London boroughs shows sustained effectiveness of IRIS
implementation over four years, with clinicians signifi-
cantly increasing referrals to DVA service providers. A
different DVA education model, focussed on conveying
information, in a comparable neighbouring borough,
more representative of usual care in the UK, did not in-
crease referrals. The difference between the boroughs
where IRIS was implemented and the other comparator
borough was substantial, with the global IRR in the
former being 30.24 whilst the IRR in the latter 0.95.
In the boroughs where IRIS was implemented, the pre-
ceding time trend confirms that this large step-wise in-
crease in referrals with IRIS training delivery was not
due to an underlying temporal trend. The other bor-
ough’s time trend before and after the delivery of its
DVA session showed no equivalent step-wise change.
Following the step-wise increase in the boroughs where
IRIS was implemented, the higher referral rate
Table 3 Referrals received by DVA service providers from general practices—incident rate ratios (IRR) with sessions’ delivery
A (n = 31) B (n = 30) C (n = 32) D (n = 23) E (n = 34)
IRR (95% CI) p IRR (95% CI) p IRR (95% CI) p IRR (95% CI) p IRR (95%) p
Underlying time trend (IRR per
day)
1.00 (0.99,
1.00)
0.157 1.00 (0.99,
1.01)
0.100 0.99 (0.99,
1.00)
0.524 0.99 (0.99,
1.00)
0.921 1.00 (0.98,
1.02)
0.681
Average effect of session
delivery
12.82 (7.51,
21.88)
< 0.001 37.92 (10.36,
138.82)
< 0.001 86.93 (27.81,
271.73)
< 0.001 30.83 (9.82,
96.76)
< 0.001 0.95 (0.13,
6.84)
0.959
Change in gradient following
session delivery
0.99 (0.998,
0.999)
0.026 0.99 (0.98,
0.99)
0.99 1.00 (0.99,
1.00)
0.853 0.99 (0.99,
1.00)
0.663 0.99 (0.98,
1.02)
0.675
Fig. 1 Average daily referral rate per 1000 women registered, in A, B,
C and D, with time centred around the point of their first IRIS
session delivery
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continued, with no significant differences across the four
boroughs, and did not vary by deprivation status of the
practice populations.
This study was sufficiently powered to detect a clinic-
ally important increase in referrals. In the four boroughs
where IRIS was implemented, with the first IRIS training
session delivery, each IRR increases (far excess of doub-
ling), reflecting the large increase in referrals made by
individual general practices with IRIS implementation—
a large relative difference in referral numbers. The wide
confidence intervals of these IRRs, in these four bor-
oughs, reflects the uncertainty about the exact point esti-
mate—but examining the lower limits of all four of these
confidence intervals (lowest 7.51 in borough A), there is
always much more than a doubling in the referrals re-
ceived by the DVA agencies from general practices. The
relative increase in referrals received with IRIS imple-
mentation was much larger than the relative increase in
recorded identification of new DVA cases. The IRIS ad-
vocate educators’ on-going support, consultancy and in-
teractions with the whole practice team, including
refresher training, conceivably have a greater impact on
referrals than on clinicians’ recording of new DVA cases.
The absolute numbers of referrals made with IRIS im-
plementation are much smaller than the numbers of
new DVA cases recorded within the EMR (in borough C
394 referrals vs 2808 cases over 3½ years), as the latter is
dependent on many external factors, including commu-
nication with other statutory organisations such as the
police, with a child safeguarding focus. In turn, the
numbers of new DVA cases recorded are smaller than
the estimates of DVA prevalence in community or
healthcare settings—using a one-year prevalence
estimate of 4.2% [29], in borough C, there would be
~ 4418 cases. This difference is unsurprising, as most
DVA is not shared outside of the home. This also in-
dicates potential gains from continuing to improve
the healthcare response to DVA.
Study strengths include no exclusion of potential bor-
ough sites, outcomes measured on a daily basis and sus-
tainability examined robustly. Data collection in the four
boroughs where IRIS was implemented surpassed the
minimum of 24months pre-specified in the sample size
Fig. 3 Forest plot comparing the estimated effect of IRIS first
training session delivery on referrals received, in A, B, C and D
Fig. 4 Forest plot comparing the estimated effect of IRIS first
training session delivery on referrals received, across three
deprivation groups in A, B, C and D.
Using the Index of Multiple Deprivation, for which “0” denotes the
least deprivation and “100” the most deprivation [28]. For the purpose
of this analysis, category boundaries were chosen to create an equal
number of practices in each group, with deprivation score grouped
into three scores: 10 to ≤ 30, low deprivation score; > 30 to < 30.65,
medium deprivation score; > 30.65, high deprivation score)
Fig. 2 Average daily referral rate per 1000 women registered in E,
with time centred around the point of their DVA session delivery
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calculation. Collecting more data than was required,
over a longer time period, gave us the capability to
evaluate the sustainability of an effect over time, rather
than only measuring the initial change in referral rate
following delivery of IRIS training. Data accuracy was
validated by coinciding sources if possible (for example,
national data compared to local data). The primary out-
come measure, referrals received by DVA service pro-
viders from general practices, was potentially susceptible
to ascertainment bias, since the agencies knew they were
part of the IRIS programme. Data collection was likely
to be the most complete in the comparison borough, as
all referrals were collected at a single site, the One-Stop
Shop, ensuring ascertainment bias was less likely here
than the IRIS implementation boroughs. Therefore, the
comparison of effect differences was conservative. Refer-
rals actually received by DVA service providers, as op-
posed to those reportedly made by clinicians, have
proved to be the most reliable measure of a healthcare
system responding to DVA [10]. This observational
study’s community setting, in routine general practice,
with borough-wide implementation, with the IRIS effect
not significantly different in the four implementation
boroughs with diverse populations, makes its results
generalisable to similar settings in the UK and poten-
tially to comparable primary care systems in high-
income countries. For lower-income countries [30], this
healthcare response to DVA is modifiable, if the health
setting is safe, using existing community resources if
DVA service infrastructure is absent.
Study limitations include not measuring direct patient-
level outcomes, using exposure to DVA advocacy as a proxy
measure, outcome assessors not blinded to data origin and
no double entry of data. DVA service providers generously
shared their data—but we did not have complete access to
the entirety of all their data sets so we were unable to assess
its completeness. In two of the IRIS implementation bor-
oughs, smaller DVA service providers, receiving less than
20% referrals, did not routinely record their client’s registered
general practice, precluding their data from the analysis.
Our study did not have any randomisation component.
However, overall, the causal inference that IRIS causes clini-
cians’ behaviour to change, increasing the referrals received
by DVA service providers, is strengthened, as it is now sup-
ported by both the preceding randomised trial, as well as this
ITS. Furthermore, the ITS analysis of the comparator
borough E without IRIS, showing no increase in the referral
rate, is also evidence that it was IRIS that was responsible for
the increase in referrals received of women affected by DVA.
Unlike other DVA work, this study is linked to a cost-
effectiveness analysis, estimating that IRIS outside the trial
setting is cost-effective from a health service and societal per-
spective, moreover good value for the NHS and cost saving
for society (the incremental net monetary benefit was £22
and £42 respectively) [31].
Conclusion
Our study provides evidence that a system-level programme
that embeds direct referral pathways to specialist DVA agen-
cies within health services, underpinned by training of clini-
cians and their teams, including on-going reinforcement
strategies and processes in place, from the outset, improves
the healthcare response to DVA. This can be successfully im-
plemented, with continued effectiveness and sustained over
four years simultaneously in multiple areas, outside of a trial
setting. Global health policy is responding to the challenge of
ensuring that health services understand their role in provid-
ing effective and compassionate healthcare in the context of
DVA [4]. For health professionals to engage effectively, inter-
nationally as well as in the UK, further resources are required
(within health and for specialist DVA agencies), best care
reconsidered and new grass root adopters of DVA pro-
grammes respected [32]. As a healthcare response to DVA is
implemented, the next step is translation research questions,
directly assessing population health impact [33]. This study
provides further evidence for funding of healthcare-based
programmes that combine direct referral pathway to special-
ist DVA services with training and on-going reinforcement.
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